Screening for Immunodeficiencies in Children With Invasive Pneumococcal Disease: Six-year Experience From a UK Children's Hospital
Journal article
Bijker EM. et al, (2022), Pediatric Infectious Disease Journal, 41, 575 - 578
Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials
Journal article
Billard MN. et al, (2022), Journal of Clinical Epidemiology, 147, 11 - 20
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
Journal article
Marchevsky NG. et al, (2022), EBioMedicine, 81
Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus.
Journal article
Sheerin D. et al, (2022), Cell Biosci, 12
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
Journal article
Li G. et al, (2022), Lancet, 399, 2212 - 2225
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.
Journal article
Rollier CS. et al, (2022), Vaccine
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.
Journal article
Shaw RH. et al, (2022), Lancet Respir Med
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial
Journal article
MAIDEN M. et al, (2022), Vaccine
Future reporting of vaccine uptake needs to include any change in ethnic or socioeconomic disparities.
Journal article
Hoang U. et al, (2022), BMJ, 377
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.
Journal article
Munro APS. et al, (2022), Lancet Infect Dis
Towards better reporting of the Proportion of Days Covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS.
Journal article
Dalli LL. et al, (2022), Br J Clin Pharmacol
Osteoarticular Infections in Pediatric Hospitals in Europe: A Prospective Cohort Study From the EUCLIDS Consortium
Journal article
Trobisch A. et al, (2022), Frontiers in Pediatrics, 10
Prevention of typhoid by Vi conjugate vaccine and achievable improvements in household WASH: Evidence from a cluster-randomized trial in Dhaka, Bangladesh.
Journal article
Tadesse BT. et al, (2022), Clin Infect Dis
Non-Tuberculous Mycobacterial Infection of the Retropharyngeal Space.
Journal article
Weng A. et al, (2022), Pediatr Infect Dis J
Next-generation T cell–activating vaccination increases influenza virus mutation prevalence
Journal article
Bull MB. et al, (2022), Science Advances, 8
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong.
Journal article
Mok CKP. et al, (2022), Respirology, 27, 301 - 310
Two-year follow-up of infant and maternal outcomes after planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
Journal article
Beardmore-Gray A. et al, (2022), BJOG